/Companies

Nia Therapeutics

Allston, US · Founded 2016 · Delaware corporation · 18 employees on LinkedIn

Find your way into Nia Therapeutics

Sign up to see every warm intro you have to Nia Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nia Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

Nia Therapeutics was founded in 2016 by Michael Kahana and Daniel Rizzuto.

MKMichael Kahana
Michael KahanaChair of Scientific Advisory Board and Co-FounderMichael Kahana is a neuroscientist whose research focuses on human memory and its neural mechanisms through behavioral, computational, and electrophysiological approaches. He earned his PhD from the University of Toronto in 1993, held postdoctoral positions at Harvard, and became a faculty member at Brandeis University; his work has produced over 230 peer-reviewed publications and includes co-editorship of the Oxford Handbook of Memory and authorship of "Foundations of Human Memory."
DR
Daniel RizzutoCo-founder
DU
Daniel UtinExecutive

Board

JW
Jonathan WachterBoard director
LG
Larry GreenbergBoard director
MM
Milton MorrisBoard director

Reported raises · per SEC filings

Form D private placements

$26.1M disclosed across 4 of 7 rounds · 2018–2024

▶$23.6MraisedJun 2026 · 37 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael KahanaExecutive Officer, Director
  • Daniel RizzutoExecutive Officer, Director
  • Jonathan WachterDirector
  • Daniel UtinExecutive Officer
  • Larry GreenbergDirector
  • Milton MorrisDirector
Offering amount
$26.5M
Amount sold
$23.6M
Minimum investment
$50K
Proceeds to insiders
$1.9M
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1offeredFeb 2024 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel RizzutoExecutive Officer, Director
  • Jonathan WachterDirector
  • Larry GreenbergDirector
  • Daniil UtinExecutive Officer
Offering amount
$1
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedSep 2020 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel RizzutoExecutive Officer, Director
  • Larry GreenbergDirector
Offering amount
$2M
Amount sold
$1.5M
First sale
Jul 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$200KraisedSep 2019 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Larry GreenbergDirector
  • Daniel RizzutoExecutive Officer, Director
Offering amount
$2M
Amount sold
$200K
First sale
Sep 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$850KraisedNov 2018 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel RizzutoExecutive Officer, Director
  • Michael KahanaExecutive Officer, Director
Offering amount
$2M
Amount sold
$850K
First sale
Oct 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Nia Therapeutics?
Nia Therapeutics was founded by Michael Kahana, Daniel Rizzuto in 2016.
How much funding has Nia Therapeutics raised?
Nia Therapeutics has disclosed $26.1M raised across 4 of its 7 known rounds.
Where is Nia Therapeutics headquartered?
Nia Therapeutics is headquartered in Allston, US.